Further analysis revealed that NTZ binds to the KLF5 protein, while the modified KLF5 is bound to the promoter region of MYBL2, a gene known to promote bone metastasis in prostate cancer, to activate its transcription (164). Here, KLF5 is linked to prostate cancer.